524606 BERLDRG

Beryl Drugs Share Price

 

 

Start SIP in BERLDRG

Start SIP

Performance

  • Low
  • ₹21
  • High
  • ₹22
  • 52 Week Low
  • ₹17
  • 52 Week High
  • ₹34
  • Open Price₹22
  • Previous Close₹22
  • Volume1,714
  • 50 DMA₹22.37
  • 100 DMA₹22.58
  • 200 DMA₹23.43

Investment Returns

  • Over 1 Month -1.12%
  • Over 3 Month -8.14%
  • Over 6 Month + 8.48%
  • Over 1 Year -34.72%

Smart Investing Starts Here Start SIP with Beryl Drugs for Steady Growth!

Invest Now

Beryl Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 785.7
  • PEG Ratio
  • -9.6
  • Market Cap Cr
  • 11
  • P/B Ratio
  • 1.2
  • Average True Range
  • 1.09
  • EPS
  • -
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.19
  • RSI
  • 48.05
  • MFI
  • 38.47

Beryl Drugs Financials

Beryl Drugs Technicals

EMA & SMA

Current Price
₹22.00
-0.11 (-0.5%)
pointer
  • Bearish Moving Average 10
  • Bullish Moving Average 6
  • 20 Day
  • ₹22.08
  • 50 Day
  • ₹22.37
  • 100 Day
  • ₹22.58
  • 200 Day
  • ₹23.43

Resistance and Support

21.69 Pivot Speed
  • R3 23.15
  • R2 22.58
  • R1 22.26
  • S1 21.37
  • S2 20.80
  • S3 20.48

Beryl Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-02-09 Quarterly Results
2026-01-03 Others
2025-11-13 Quarterly Results
2025-09-02 A.G.M.
2025-08-07 Quarterly Results

Beryl Drugs F&O

Beryl Drugs Shareholding Pattern

26.38%
66.25%
7.37%

About Beryl Drugs

  • NSE Symbol
  • BERLDRG
  • BSE Symbol
  • 524606
  • Managing Director
  • Mr. Sanjay Sethi
  • ISIN
  • INE415H01017

Similar Stocks to Beryl Drugs

Beryl Drugs FAQs

Beryl Drugs share price is ₹22 As on 15 February, 2026 | 07:31

The Market Cap of Beryl Drugs is ₹11.2 Cr As on 15 February, 2026 | 07:31

The P/E ratio of Beryl Drugs is 785.7 As on 15 February, 2026 | 07:31

The PB ratio of Beryl Drugs is 1.2 As on 15 February, 2026 | 07:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23